Elekta hits radiotherapy milestone with 5,000th linear accelerator manufactured
Radiation therapy system delivered to Korea’s Hallym University Kangnam Sacred Heart HospitalCRAWLEY, United Kingdom, March 8, 2019 – With the number of new cancer cases globally expected to rise by about 70 percent over the next two decades1-2, access to radiotherapy – a key treatment modality for up to 60 percent of cancer patients – is more critical than ever. Since the manufacture of its first linear accelerator (linac) six decades ago, Elekta (EKTA-B.ST) has been committed to providing radiotherapy systems to every corner of the world. Hallym University Kangnam Sacred Heart Hospital (